Vicarious Surgical (RBOT) Net Income Growth (3y) (2023 - 2025)
Vicarious Surgical (RBOT) Net Income Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn | 2.38% |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn | 60.12% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 280.49% |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 23.54% |
| Jun 30, 2025 | -108.74% |
| Mar 31, 2025 | -33.18% |
| Dec 31, 2024 | -38.19% |
| Sep 30, 2024 | 27.65% |
| Jun 30, 2024 | -31.82% |
| Mar 31, 2024 | -48.13% |
| Dec 31, 2023 | -51.32% |
| Sep 30, 2023 | -67.51% |
| Jun 30, 2023 | -731.18% |